Stockreport
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Intrexon Corporation (XON)
Last intrexon corp earnings: 11/8 04:10 pm
Check Earnings Report
US:NYSE Investor Relations: investors.dna.com
| IMPACT SNAPSHOT | EVENT TIME: | XON | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
XON alerts
XON alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
XON alerts
High impacting Intrexon Corp news events
Weekly update
A roundup of the hottest topics
XON
NEWS
NEWS
- Intrexon to Announce Fourth Quarter 2018 Financial Results on February 28th[PR Newswire]
- Intrexon's Subsidiary Precigen to Present at the SVB Leerink 8th Annual Global Healthcare Conference[PR Newswire]
- Precigen Announces Clearance of IND to Initiate Phase 1 Study for First-in-Class PRGN-3005 UltraCAR-T™ to Treat Advanced Stage Platinum Resistant Ovarian Cancer Patients[PR Newswire]
- Intrexon Corp (NYSE: XON) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $9.00 price target on the stock.[MarketBeat]
- Intrexon Corp (NYSE: XON) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.[MarketBeat]
- More
XON
SEC Filings
SEC Filings
- 2/21/19 - Form 4
- 2/14/19 - Form 4
- 2/11/19 - Form 4
- XON's page on the SEC website
- More